Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elie Rassy

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Immunotherapy|June 13, 2019
The interaction of immune checkpoint inhibitor plus chemotherapy in non-small-cell lung cancer: subadditivity, additivity or synergism?Elie Rassy, Ziad Bakouny, Tarek Assi, et al.
International Review of Cell and Molecular Biology|March 30, 2023
Impact of radiation therapy on healthy tissuesCyrus Chargari, Elie Rassy, Carole Helissey, et al.
Critical Reviews in Oncology/Hematology|February 28, 2020
New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?Elie Rassy, Pauline Parent, Felix Lefort, et al.
Clinical Genitourinary Cancer|August 23, 2022
Antibody-Drug Conjugates in Prostate Cancer: Where Are we?Georges Mjaess, Fouad Aoun, Elie Rassy, et al.
Annals of Translational Medicine|January 25, 2021
Narrative review on serous primary peritoneal carcinoma of unknown primary site: four questions to be answeredElie Rassy, Tarek Assi, Stergios Boussios, et al.
Annals of Translational Medicine|January 25, 2021
Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?Michele Moschetta, Stergios Boussios, Elie Rassy, et al.
Cancer Treatment Reviews|July 5, 2020
A comprehensive overview of promising biomarkers in stage II colorectal cancerPauline Parent, Romain Cohen, Elie Rassy, et al.
Current Research in Translational Medicine|July 21, 2023
Advances in adoptive T-cell therapy for metastatic melanomaAparimita Das, Aruni Ghose, Kevin Naicker, et al.
Diagnostics (Basel, Switzerland)|August 4, 2019
Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature ReviewStergios Boussios, Peeter Karihtala, Michele Moschetta, et al.
The Gulf Journal of Oncology|April 29, 2020
ALK gene rearrangement status in non-squamous non-small cell lung carcinoma in the Middle Eastern populationSamah El Naderi, Rosy Abou-Jaoude, Marc Rassy, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Immunotherapy|June 13, 2019
The interaction of immune checkpoint inhibitor plus chemotherapy in non-small-cell lung cancer: subadditivity, additivity or synergism?Elie Rassy, Ziad Bakouny, Tarek Assi, et al.
International Review of Cell and Molecular Biology|March 30, 2023
Impact of radiation therapy on healthy tissuesCyrus Chargari, Elie Rassy, Carole Helissey, et al.
Critical Reviews in Oncology/Hematology|February 28, 2020
New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?Elie Rassy, Pauline Parent, Felix Lefort, et al.
Clinical Genitourinary Cancer|August 23, 2022
Antibody-Drug Conjugates in Prostate Cancer: Where Are we?Georges Mjaess, Fouad Aoun, Elie Rassy, et al.
Annals of Translational Medicine|January 25, 2021
Narrative review on serous primary peritoneal carcinoma of unknown primary site: four questions to be answeredElie Rassy, Tarek Assi, Stergios Boussios, et al.
Annals of Translational Medicine|January 25, 2021
Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?Michele Moschetta, Stergios Boussios, Elie Rassy, et al.
Cancer Treatment Reviews|July 5, 2020
A comprehensive overview of promising biomarkers in stage II colorectal cancerPauline Parent, Romain Cohen, Elie Rassy, et al.
Current Research in Translational Medicine|July 21, 2023
Advances in adoptive T-cell therapy for metastatic melanomaAparimita Das, Aruni Ghose, Kevin Naicker, et al.
Diagnostics (Basel, Switzerland)|August 4, 2019
Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature ReviewStergios Boussios, Peeter Karihtala, Michele Moschetta, et al.
The Gulf Journal of Oncology|April 29, 2020
ALK gene rearrangement status in non-squamous non-small cell lung carcinoma in the Middle Eastern populationSamah El Naderi, Rosy Abou-Jaoude, Marc Rassy, et al.
Pageof 10